October 14, 2014 — The U.S. Food and Drug Administration (FDA) approved Lumason (sulfur hexafluoride lipid microsphere) ...
Contrast Media
Contrast media, also called contrast agents, are used to enhance the blood and perfusion in tissues. This includes iodine based contrast for on computed tomography (CT), gadolinium based agents for MRI and lipid bubble contrast agents used in ultrasound.
The use of contrast media in many imaging modalities continues to evolve as physicians seek to improve dose management ...
September 30, 2014 — The U.S. Food and Drug Administration has allowed marketing of the NephroCheck test, a first-of-a ...
Bayer Radiology’s Barbara Ruhland and Thom Kinst discuss how radiology departments can address the many different ...
September 25, 2014 — Mallinckrodt announced the U.S. launch of the OptiSync data management system as a new technology ...
September 10, 2014 — According to new research performed at the Mayo Clinic, iodine-based contrast material injected ...
August 14, 2014 — A multi-institutional team of researchers has developed a new nanoscale agent for imaging the ...
Bracco Diagnostics and Guerbet recently announced they had formed a strategic, global collaboration for the research ...
August 11, 2014 — Imaging experts from the American Society of Echocardiography (ASE) released a paper, "Guidelines for ...
July 24, 2014 — Scientists have designed a new self-assembling nanoparticle that targets tumors, to help doctors ...
July 16, 2014 — In your bones, there is fat. Why? Researchers do not know, but they have theories. How does it get there ...
A patient’s chance of recovery can be directly impacted when a diagnosis is missed or delayed. To get the right ...
July 3, 2014 — The American Society of Echocardiography Foundation (ASEF) launched the second version of its free mobile ...
June 20, 2014 — Bayer HealthCare announced the U.S. Food and Drug Administration (FDA) approved a new indication for ...
April 18, 2014 — Guerbet announced that Lipiodol was approved by the U.S. Food and Drug Administration (FDA), indicated ...
Product Indications and Use: CLARISCAN (gadoterate meglumine) is a gadolinium-based contrast agent indicated for ...
April 4, 2014 — GE Healthcare announced results from a new clinical study, which showed that patients receiving ...
March 26, 2014 – Manhattan Scientifics announced a collaboration with Azano Biotech that will make NanoMRX Precision ...
March 11, 2014 — Guerbet announced a worldwide launch of FlowSens, a contrast agent injection solution used in X-ray ...
March 5, 2014 — Researchers at the Cedars-Sinai Maxine Dunitz Neurosurgical Institute and Department of Neurosurgery ...
February 20, 2014 — Guerbet, a contrast agent specialist for medical imaging, received U.S. Food and Drug Administration ...
January 31, 2014 — Researchers at the University of North Carolina at Chapel Hill have achieved higher resolution ...
December 18, 2013 — For the first time, researchers have confirmed an association between a common magnetic resonance ...
November 26, 2013 — Researchers say they have achieved enough coherence of the magnetic moment inherent in the defects ...
October 14, 2014 